Skip to main content
OpenTrials
Completed

NCT Number: NCT01469312

Effect of Pasta on Blood Glucose Response in Normal Subjects

The objective of this study is to determine whether ingestion of modified pasta products (Dreamfields, Miracle Noodles) result in an improvement in blood glucose concentration when compared with a traditional pasta.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minneapolis VA Health Care System

Minneapolis, Minnesota, 55417, United States

About this study

On one occasion the pasta will be a traditionally available pasta; on another occasion, approximately 1 week later a modified pasta, advertised to contain ~ 5 grams of digestible carbohydrate, or to be low in digestible starch, will be studied.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normal blood glucose concentration

Treatment and study plan

modified pasta

Other

50 grams carbohydrate as a single breakfast meal

Other names: Dreamfields Pasta, Miracle Noodles

Primary outcomes

  1. Change in Blood Glucose

    Time frame: 0, 30, 60, 90, 120, and 180 minutes after ingestion

    Blood glucose will be determined by finger stick.

Sponsors and collaborators

Lead sponsor

Minneapolis Veterans Affairs Medical Center

Fed

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Nov 10, 2011
Registry last updated
Nov 11, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.